1 Ocak 2020 Dergi makalesi Açık Erişim

Dabak, Murat; Dabak, Durrin O.; Kuloglu, Tuncay; Baydar, Ersoy; Bulut, Hakan; Ozoner, Ozgur

Dublin Core

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Dabak, Murat</dc:creator>
  <dc:creator>Dabak, Durrin O.</dc:creator>
  <dc:creator>Kuloglu, Tuncay</dc:creator>
  <dc:creator>Baydar, Ersoy</dc:creator>
  <dc:creator>Bulut, Hakan</dc:creator>
  <dc:creator>Ozoner, Ozgur</dc:creator>
  <dc:date>2020-01-01</dc:date>
  <dc:description>Background: Extrarenal 1 alpha,25-dihydroxyvitamin D-3 (1,25-D) locally produced by immune cells plays crucial roles in the regulation of the immune system. However, in vivo status of extrarenal 1,25-D and 25-hydroxyvitamin D (25-D) in acute inflammatory conditions are unknown.</dc:description>
  <dc:identifier>https://aperta.ulakbim.gov.trrecord/5311</dc:identifier>
  <dc:identifier>oai:zenodo.org:5311</dc:identifier>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>http://www.opendefinition.org/licenses/cc-by</dc:rights>
  <dc:source>ENDOCRINE METABOLIC &amp; IMMUNE DISORDERS-DRUG TARGETS 20(9) 1523-1530</dc:source>
  <dc:title>Increased Circulatory Extrarenal 1 alpha,25-Dihydroxyvitamin D3 in Bilaterally Nephrectomized Rats</dc:title>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:type>publication-article</dc:type>
</oai_dc:dc>